Compounds > carbachol
Page last updated: 2024-11-07

carbachol and Atherosclerotic Parkinsonism

carbachol has been researched along with Atherosclerotic Parkinsonism in 3 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atadzhanov, M1
Matthews, RT1
Chiou, CY1
Wolfarth, S1

Reviews

2 reviews available for carbachol and Atherosclerotic Parkinsonism

ArticleYear
[Modeling parkinsonism (review)].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1982, Volume: 82, Issue:3

    Topics: Aluminum; Animals; Carbachol; Cats; Caudate Nucleus; Chlorides; Chlorpromazine; Disease Models, Anim

1982
Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Polish journal of pharmacology and pharmacy, 1976, Volume: 28, Issue:5

    Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior, Animal; Brain; Carbachol; Caudate Nucleus; C

1976

Other Studies

1 other study available for carbachol and Atherosclerotic Parkinsonism

ArticleYear
Effects of diethylcholine in two animal models of Parkinsonism tremors.
    European journal of pharmacology, 1979, Volume: 56, Issue:1-2

    Topics: Animals; Brain Chemistry; Carbachol; Choline; Disease Models, Animal; Male; Mice; Parkinson Disease,

1979